Unicorn Alert: This Strange Gas Poses a HUGE Problem For Semiconductors…
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. That's why this one company could explode over 2021.
Click Here To See This Incredibly Valuable Gas

LYRA Insider Trading (Lyra Therapeutics)

Insider Ownership Percentage: 16.40%
Insider Buying (Last 12 Months): $31,395.00
Insider Selling (Last 12 Months): $0.00

Lyra Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Lyra Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lyra Therapeutics Share Price & Price History

Current Price: $7.57
Price Change: Price Decrease of -0.34 (-4.30%)
As of 10/19/2021 03:52 PM ET

This chart shows the closing price history over time for LYRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Seattle Cannabis Company Capitalizes on Surging Demand
The increase in the number of states that permit recreational and medical use of cannabis means that growers, processors and manufacturers of cannabis products often can't keep up with growing demand. One Seattle weed manufacturer is poised to sell products across state lines, easing shortages. This could drive the company's shares sky-high.
Get all the details on this potential blockbuster!

Lyra Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/17/2021C. Ann MerrifieldDirectorBuy3,500$8.97$31,395.003,500View SEC Filing Icon  
5/5/2020Edward T AndersonDirectorSell24,183$15.79$381,849.57226,833
5/5/2020Edward T AndersonDirectorBuy250,000$15.79$3,947,500.00
5/5/2020Polaris Venture Partners SpeciMajor ShareholderBuy62,500$15.79$986,875.00
5/5/2020Polaris Venture Partners SpeciMajor ShareholderSell9,674$15.79$152,752.4652,826
See Full Table
Insider Selling at Lyra Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Lyra Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Lyra Therapeutics (NASDAQ:LYRA)

53.70% of Lyra Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LYRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Lyra Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/25/2021Marshall Wace LLP19,321$0.16M0.0%-58.8%0.149%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley85,411$0.69M0.0%-20.3%0.657%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC624,684$5.02M0.4%-20.0%4.805%Search for SEC Filing on Google Icon
8/17/2021Walleye Capital LLC19,093$0.15M0.0%N/A0.147%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC155,135$1.25M0.0%N/A1.193%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC19,381$0.16M0.0%N/A0.149%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC41,900$0.34M0.0%-14.5%0.322%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley85,411$0.69M0.0%-20.3%0.657%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd40,000$0.32M0.1%N/A0.308%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP19,321$0.16M0.0%-58.8%0.149%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC36,102$0.29M0.0%-60.0%0.278%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.220,029$1.77M0.0%+3.8%1.692%Search for SEC Filing on Google Icon
8/12/2021Trexquant Investment LP11,610$93K0.0%N/A0.089%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC31,000$0.25M0.0%N/A0.238%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG76,441$0.61M0.0%-5.4%0.588%Search for SEC Filing on Google Icon
8/11/2021Susquehanna International Group LLP21,529$0.17M0.0%N/A0.166%Search for SEC Filing on Google Icon
8/2/2021Advisor Group Holdings Inc.4,434$36K0.0%-89.6%0.034%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley107,217$1.24M0.0%+655.0%0.825%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC17,913$0.21M0.0%N/A0.138%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC780,728$9.05M0.3%-4.2%6.005%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp15,036$0.17M0.0%-22.7%0.116%Search for SEC Filing on Google Icon
5/13/2021Blair William & Co. IL55,000$0.64M0.0%N/A0.424%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp64,451$0.75M0.0%-5.2%0.497%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC90,281$1.05M0.0%+31.8%0.696%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.147,400$1.71M0.0%-22.8%1.137%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.348,394$4.04M0.0%+31.9%2.688%Search for SEC Filing on Google Icon
5/4/2021Envestnet Asset Management Inc.36,792$0.43M0.0%N/A0.284%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.191,000$2.18M0.0%+9,858.3%1.478%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.14,177$0.16M0.0%N/A0.110%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.3,954$45K0.0%+60.9%0.031%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC815,364$9.30M0.4%+110.2%6.307%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp67,995$0.78M0.0%+39.1%0.526%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN3,521$40K0.0%+225.1%0.027%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp19,450$0.22M0.0%+24.3%0.150%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.264,165$3.01M0.0%+27.4%2.044%Search for SEC Filing on Google Icon
11/16/2020ArrowMark Colorado Holdings LLC788,215$8.81M0.1%+293.8%6.097%Search for SEC Filing on Google Icon
11/16/2020Boothbay Fund Management LLC43,664$0.49M0.0%N/A0.338%Search for SEC Filing on Google Icon
11/10/2020State Street Corp45,506$0.51M0.0%+7.2%0.352%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.207,326$2.32M0.0%+1.0%1.604%Search for SEC Filing on Google Icon
11/5/2020New York State Common Retirement Fund4,438$50K0.0%-44.5%0.034%Search for SEC Filing on Google Icon
10/20/2020Nisa Investment Advisors LLC16,210$0.18M0.0%N/A0.125%Search for SEC Filing on Google Icon
8/24/2020ArrowMark Colorado Holdings LLC200,180$2.27M0.0%N/A1.548%Search for SEC Filing on Google Icon
8/18/2020Blackstone Group Inc25,000$0.28M0.0%N/A0.193%Search for SEC Filing on Google Icon
8/17/2020Perceptive Advisors LLC3,222,561$36.54M0.6%N/A24.933%Search for SEC Filing on Google Icon
8/14/2020Bank of America Corp DE110,990$1.26M0.0%N/A0.859%Search for SEC Filing on Google Icon
8/13/2020Federated Hermes Inc.30,000$0.34M0.0%N/A0.232%Search for SEC Filing on Google Icon
8/12/2020Ensign Peak Advisors Inc15,000$0.17M0.0%N/A0.116%Search for SEC Filing on Google Icon
8/12/2020American International Group Inc.2,513$28K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/12/2020Polaris Venture Management Co. V L.L.C.1,100,852$12.48M9.7%N/A8.517%Search for SEC Filing on Google Icon
8/12/2020Goldman Sachs Group Inc.25,600$0.29M0.0%N/A0.198%Search for SEC Filing on Google Icon
8/12/2020Bank of New York Mellon Corp13,248$0.15M0.0%N/A0.102%Search for SEC Filing on Google Icon
8/7/2020New York State Common Retirement Fund8,000$91K0.0%N/A0.062%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Lyra Therapeutics logo
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. Its product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.
Read More on Lyra Therapeutics

Today's Range

Now: $7.57
Low: $7.48
High: $7.66

50 Day Range

MA: $8.02
Low: $6.48
High: $9.43

52 Week Range

Now: $7.57
Low: $5.83
High: $16.50

Volume

848 shs

Average Volume

108,161 shs

Market Capitalization

$98.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.45

Who are the company insiders with the largest holdings of Lyra Therapeutics?

Lyra Therapeutics' top insider shareholders include:
  1. Edward T Anderson (Director)
  2. Polaris Venture Partners Speci (Major Shareholder)
  3. C Ann Merrifield (Director)
  4. Mukesh Mehta (EVP)
Unicorn Alert: This Strange Gas Poses a HUGE Problem For Semiconductors…
This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. That's why this one company could explode over 2021.
Click Here To See This Incredibly Valuable Gas